博雅生物 (300294)
China Resources Boya Bio-pharmaceutical Group Co., Ltd
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 50424.87
- Circulating A-Shares(W): 50424.87
- Earnings Per Share(RMB): 0.6800
- Net Assets Per Share(RMB): 15.2122
- Operating Revenue(W RMB): 147392.41
- Total Profit(W RMB): 34133.48
- Net Profit Attributable to Parent(W RMB): 34296.18
- Net Profit Growth Rate(%): -16.90
- Weighted Return on Equity(%): 4.5000
- Operating Cash Flow Per Share(RMB): 0.0520
- Undistributed Profit Per Share(RMB): 5.6561
- Capital Reserve Per Share(RMB): 8.0575
2. Main Business
The main business covers:
- Research, development, production, and sales of blood products
3. Company Basic Information
- Company Name: China Resources Boya Bio-pharmaceutical Group Co., Ltd.
- Listing Date: 2012-03-08
- Industry: Pharmaceutical Manufacturing
- Address: No.333 Huiquan Road, Fuzhou High-tech Industrial Development Zone, Jiangxi Province
- Website: www.china-boya.com
- Company Profile: Jiangxi Boya Bio-pharmaceutical Co., Ltd. was established as a joint-stock company through a corporate restructuring of Jiangxi Boya Bio-pharmaceutical Co., Ltd. The restructuring was based on the audited net assets of 44,359,122 yuan as of November 30, 2000, converted into 44,359,122 shares at a 1:1 ratio. The founding meeting of the joint-stock company was held on February 1, 2001. On February 5, 2001, Zhonglei Certified Public Accountants Co., Ltd. issued the “Zhonglei Yan Zi (2001) No. 2003” “Capital Verification Report” for the company’s establishment, confirming that the registered capital had been fully paid by the promoters. On February 15, 2001, the company obtained the “Business License” issued by the Jiangxi Provincial Administration for Industry and Commerce, with registration number 3625001100423.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Resources Pharmaceutical Holdings Co., Ltd. | General Legal Person | 15369.15 | 30.48 |
| 2 | Shenzhen Gaotejia Investment Group Co., Ltd. | General Legal Person | 5704.96 | 11.31 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 888.43 | 1.76 |
| 4 | Fuzhou Jiayi Investment Partnership (Limited Partnership) | General Legal Person | 662.18 | 1.31 |
| 5 | China Merchants Guozheng Bio-pharmaceutical Index Securities Investment Fund (LOF) Class A | Fund | 434.18 | 0.86 |
| 6 | Nanchang Dazheng Chuyuan Investment Co., Ltd. | General Legal Person | 281.11 | 0.56 |
5. Concept Sectors
- Biological Vaccines
- Hepatitis Concept
- Margin Trading & Securities Lending
- High-Performance Stocks
- Special Loans
- ChiNext 300
- CSI Central Enterprises
- ChiNext Pharmaceuticals
- ChiNext 200
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information